Recombinant Human Serpin A5,Protein C Inhibitor (C-6His)

Uniprot :
P05154

Description:
Cathepsin Inhibitor 1 is a protein that inhibits the activity of cathepsins, which are enzymes that play a role in the degradation of proteins. Cathepsin Inhibitor 1 has shown to inhibit actin filament assembly and is currently being investigated as a potential drug for the treatment of viral infections, including HIV and influenza. Cathepsin inhibitor 1 also has anti-cancer properties, blocking cell necrosis and inducing autophagy. It is thought that this protein may be involved in the regulation of syncytium formation during virus replication, potentially leading to new treatments for syncytial viruses such as HIV.

Uniprot :
Q8BJ56

Description:
Duloxetine is a serotonin and norepinephrine reuptake inhibitor drug that is used to treat anxiety, pain, osteoarthritis and stress incontinence. This drug inhibits the reuptake of the neurotransmitters serotonin and norepinephrine so that there are increased levels of them in the synaptic cleft. Duloxetine HCl is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease

Uniprot :
P28700

Description:
Ochromycinone is a neurotrophic factor that has been shown to inhibit the growth of skin cancer cells. It has been shown to induce the production of neurotrophic factors, which are proteins that promote neuronal survival and growth. Ochromycinone also has biological properties that have been associated with cellular transformation and tumorigenesis. This protein binds to dinucleotide phosphate (DNP) and inhibits polymerase chain reaction (PCR) by binding to DNA in vitro. Ochromycinone may be a potential drug target for infectious diseases such as HIV or herpes simplex virus infections. It has also been shown to inhibit Toll-like receptor (TLR) signaling pathways in experimental models.

Uniprot :
Q9UH03

Description:
R-IMPP is a small molecule that has been shown to inhibit cholesterol synthesis. The inhibition of cholesterol synthesis by R-IMPP leads to the lowering of low-density lipoprotein-cholesterol and uptake, which in turn prevents the formation of atherosclerotic lesions. R-IMPP has also been shown to be an effective treatment for high blood pressure. This drug is currently being evaluated in clinical trials for its potential use as a protein target, translation inhibitor, and serine protease inhibitor.

Uniprot :
P50753

Description:
Cyamemazine is a medication used to treat schizophrenia in adults. It is an antipsychotic drug that blocks dopamine receptors, which may help to reduce psychotic symptoms. Cyamemazine belongs to the family of phenothiazines, which are a class of drugs called dopamine receptor blockers. The rate constant for cyamemazine has been determined by analytical methods and found to be 1.3 x 10-4 M-1s-1. Control analysis has also been performed on cyamemazine and shown that it does not interact with 5-HT2C receptors or locomotor activity in rats. Cyamemazine is metabolized by the liver into a variety of metabolites, including one called cyamemazine sulfoxide, which can bind to cardiac tissue and cause cardiotoxicity in humans. Cyamemazine has been shown to have some effects on wastewater treatment, such as the removal of chlorophenols and phthalates from wastewater effluents.